Descubra el nuevo Chem-Impex: donde la innovación comienza con un vínculo.

Catalog Number:
38240
CAS Number:
112887-68-0
Raltitrex
Purity:
≥ 98 % (HPLC)
Synonym(s):
Ácido N -[[5-[[(1,4-Dihidro-2-metil-4-oxo-6-quinazolinil)metil]metilamino]-2-tienil]carbonil]-L-glutámico, ICI-D-1694
Hazmat
Documents
$334.10 /50 mg
Tamaño
Request Bulk Quote
Información del producto
Número CAS
112887-68-0
Fórmula molecular
C21H22N4O6S
Peso molecular
0
Número MDL
MFCD00864168
Punto de fusión
176 °C (descenso)
Rotación óptica
[a] D 20 = -15 a -20 ° (C=1 en MeOH)
Condiciones
Conservar a < 0 °C
Información general
Número CAS
112887-68-0
Fórmula molecular
C21H22N4O6S
Peso molecular
0
Número MDL
MFCD00864168
Punto de fusión
176 °C (descenso)
Rotación óptica
[a] D 20 = -15 a -20 ° (C=1 en MeOH)
Condiciones
Conservar a < 0 °C
Propiedades
¡Pronto habrá más información sobre la propiedad!
-
Seguridad y normativas
Materiales peligrosos
-
Antibiótico
-
Regulado por la DEA
No
Advertencias
-
Aplicaciones

Raltitrexed is widely utilized in research focused on

  • Cancer Treatment: This compound is primarily used as an anti-cancer agent, particularly in the treatment of colorectal cancer. It acts as a thymidylate synthase inhibitor, disrupting DNA synthesis in rapidly dividing cancer cells.
  • Pharmaceutical Development: Raltitrexed serves as a critical reference compound in the development of new anti-cancer drugs. Researchers study its mechanisms to design more effective therapies with fewer side effects.
  • Combination Therapies: It is often used in combination with other chemotherapeutic agents to enhance treatment efficacy. This synergistic approach can improve patient outcomes in various cancer types.
  • Clinical Trials: Raltitrexed is frequently involved in clinical trials aimed at evaluating new treatment regimens. Its established profile helps researchers assess the effectiveness of novel therapeutic strategies.
  • Research on Drug Resistance: Scientists study Raltitrexed to understand mechanisms of drug resistance in cancer cells. Insights gained can lead to the development of strategies to overcome resistance and improve treatment success.

Citas